BMY
Bristol-Myers SquibbCNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
BMY vs peer average
42/100
BMY vs. peer average (C vs. B)
Grade spread
A 1 · B 5 · C 2 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
JNJ is the first available peer comparator.
Large diversified pharma with broad consumer/medtech exposure; defensive revenue mix compared with BMY's oncology focus.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
BMY
Bristol-Myers Squibb
JNJ
Johnson Johnson
Grade
C
B
Momentum
54
51
Value
68
62
Sentiment
47
64
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs JNJ
BMY / JNJ
Grade Position
Below peers
BMY vs. peer average (C vs. B)
42/100
Momentum
54
BMYValue
68
BMYSentiment
47
JNJRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs BMY
JNJ is the first peer returned for this comparison set.

